DDFG Inc’s Gilead Sciences GILD Stock Holding History

DDFG Inc’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Buy	2,295 +7	+0.3%	+$922	0.06%	77
2026 Q1	$319K	Buy	2,288 +12	+0.5%	+$1.68K	0.07%	68
2025 Q4	$279K	Buy	2,276 +36	+2%	+$4.38K	0.06%	73
2025 Q3	$249K	Buy	2,240 +14	+0.6%	+$1.59K	0.06%	74
2025 Q2	$247K	Buy	2,226 +13	+0.6%	+$1.38K	0.06%	70
2025 Q1	$248K	Sell	2,213 -783	-26%	-$80.8K	0.07%	65
2024 Q4	$277K	Buy	2,996 +21	+0.7%	+$1.89K	0.08%	65
2024 Q3	$249K	Buy	+2,975	New	+$227K	0.07%	69
2024 Q1	–	Sell	-4,319	Closed	-$350K	–	76
2023 Q4	$350K	Buy	4,319 +41	+1%	+$3.19K	0.12%	54
2023 Q3	$321K	Buy	4,278 +42	+1%	+$3.23K	0.12%	54
2023 Q2	$327K	Buy	4,236 +41	+1%	+$3.27K	0.12%	54
2023 Q1	$348K	Buy	4,195 +39	+0.9%	+$3.23K	0.14%	51
2022 Q4	$357K	Buy	+4,156	New	+$329K	0.15%	47

Other funds holding GILD

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

DDFG Inc's GILD Position: Q2 2026 in Review

DDFG Inc increased its Gilead Sciences (GILD) stake by 0.31% in Q2 2026, buying an estimated $922 and bringing the position to 2,295 shares worth $290K. The position accounts for 0.06% of the portfolio, ranked #77.

DDFG Inc first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. The position peaked at $357K in Q4 2022. 1,095 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

DDFG Inc held 2,295 shares of Gilead Sciences worth $290K as of Q2 2026.
DDFG Inc bought 7 Gilead Sciences shares in Q2 2026, an estimated $922.
Gilead Sciences made up 0.06% of DDFG Inc's portfolio in Q2 2026, its #77 holding.
DDFG Inc first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
DDFG Inc's Gilead Sciences position peaked at $357K in Q4 2022.
1,095 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on DDFG Inc's 13F filing for Q2 2026, filed 28 Jul 2026.